Phacet

Based in Overijssel, Netherlands, and founded in 2024 by Chief Executive Officer Nicolas Marchais, Farmaco-Logica B. V. doing business as Phacet, operates as a software company providing digital support for pharmacological and pharmaceutical patient care. In September 2024, Phacet raised EUR 4 million in seed funding from Motier Ventures, Aglaé Ventures, Emblem, Origins Capital Partners, and many more.

  Phacet specializes in offering software solutions to healthcare professionals, improving their ability to apply scientific insights in patient care. It developed a product known as the Phacet Compound Server, which is an open-source platform designed to manage the compounding and dispensing of pharmaceuticals. The company’s platform integrates with existing prescribing systems and automates compounding processes. In addition, the platform’s features include proposal modifications based on pharmaceutical requirements, user interfaces for workflow management, and integration with robotic systems for automated compounding.

Phacet maintains Phacet. info, which is a knowledge base on drug dosing in obesity and post-bariatric surgery, providing healthcare professionals with access to critical pharmacological and toxicological information.   The company plans to use the funding From September 2024 to build a bridge between fast-evolving AI models and the concrete needs of SMEs by integrating AI into its implementation in different departments.